je.st

Home › gilead

Tag: gilead

Valuing Gilead Sciences Based On Free Cash Flow Projections

2016-03-08 21:07:01| Biotech - Topix.net

I anticipate that the company will continue to maintain its competitive advantage for HIV and Hepatitis C products. However, regulatory pressure on pricing remains less certain.

Tags: free based cash flow

Gilead Sciences, Inc. (GILD) Shares Bought by Excalibur Management Corp

2016-03-06 13:53:43| Biotech - Topix.net

Excalibur Management Corp boosted its stake in Gilead Sciences, Inc. by 1.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 29,365 shares of the biopharmaceutical company's stock after buying an additional 365 shares during the period.

Tags: management bought sciences corp

Gilead Has Bottomed - The Question Is How Much Upside Ahead?

2016-02-16 05:34:09| Biotech - Topix.net

It has been a frightful six months for biotech investors as the main biotech indices have plunged some 40% from their peaks in July. However, it does appear the some of the big biotech names are in a bottoming phase which is needed before the sector can rally.

Tags: much question ahead upside

Gilead Sciences beats 4th-quarter forecasts on higher sales

2016-02-03 10:33:31| Biotech - Topix.net

Gilead Sciences Inc. posted a 34 per cent increase in fourth-quarter profit, trouncing Wall Street expectations, as sales of its blockbuster hepatitis C drugs soared in Japan and offset lower sales in the U.S. The maker of Harvoni, the first once-daily, single-pill regimen for hepatitis C, and predecessor drug Sovaldi, has been propelled by the lucrative franchise since Sovaldi was launched at the end of 2013. They're the main reason the company's revenue has tripled in just two years, a rare accomplishment in the industry.

Tags: sales higher sciences beats